ALFRED ALTOMARI
CIK 1285644 · Chief Executive Officer · last filed 2024-08-26
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$6.80M
Companies
7
Total Filings
80
Lifetime Open-Market Net
-$1.20M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| INSM | Director | 69,495 | $97.85 | $6.80M | -$1.37M | 18 | 2024-05-15 |
| AGILE THERAPEUTICS INC (AGRX) Delisted | Chief Executive Officer | 38,786 | $1.51 | $58.6K | $332.7K | 31 | 2023-06-30 |
| Baudax Bio, Inc. (BXRX) Delisted | Director | 117,785 | $0.02 | $2.6K | $17.0K | 5 | 2021-04-08 |
| Societal CDMO, Inc. (REPH) Delisted | Director | 44,196 | $2.09 | $92.4K | $9.8K | 10 | 2019-12-09 |
| DUSA | Director | 0 | $56.18 | $0 | $13.2K | 6 | 2012-12-20 |
| AUXILIUM PHARMACEUTICALS INC (AUXL) Delisted | Director | 0 | — | — | -$199.9K | 6 | 2011-06-20 |
| BARRIER THERAPEUTICS INC (BTRX) Delisted | Chief Executive Officer | 0 | — | — | $0 | 3 | 2008-08-06 |
Recent Filings · Page 2 of 8
80 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2021-05-19 | AGILE THERAPEUTICS INC (AGRX) Delisted | Buy (P) | +20,000 | $32.2K | EDGAR |
| 2021-05-14 | INSM | Grant (A) | +7,558 | $0 | EDGAR |
| 2021-04-08 | Baudax Bio, Inc. (BXRX) Delisted | Grant (A) | +56,452 | $0 | EDGAR |
| 2021-03-23 | AGILE THERAPEUTICS INC (AGRX) Delisted | Buy (P) | +12,500 | $25.0K | EDGAR |
| 2021-01-28 | AGILE THERAPEUTICS INC (AGRX) Delisted | Grant (A) | — | $0 | EDGAR |
| 2020-12-09 | INSM | Sell (S) | −20,000 | -$791.4K | EDGAR |
| 2020-11-24 | Baudax Bio, Inc. (BXRX) Delisted | Buy (P) | +5,000 | $5.3K | EDGAR |
| 2020-08-20 | AGILE THERAPEUTICS INC (AGRX) Delisted | Exer (M) | +94,599 | $166.5K | EDGAR |
| 2020-06-23 | AGILE THERAPEUTICS INC (AGRX) Delisted | Exer (M) | +50,000 | $88.0K | EDGAR |
| 2020-05-14 | INSM | Grant (A) | +8,097 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.